Characteristics of clinical Shiga toxin-producing Escherichia coli isolated from British Columbia.

about

Evaluation of enzyme immunoassays and real-time PCR for detecting Shiga toxin-producing Escherichia coli in Southern Alberta, Canada.

P2860

Q35331035-969B90D9-7161-462F-A74B-E2EC9422AF8A

P2860

Characteristics of clinical Shiga toxin-producing Escherichia coli isolated from British Columbia.

Item

http://www.wikidata.org/entity/Q42935507

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Characteristics of clinical Sh ...... solated from British Columbia.

@en

Characteristics of clinical Sh ...... solated from British Columbia.

@nl

type

Item

label

Characteristics of clinical Sh ...... solated from British Columbia.

@en

Characteristics of clinical Sh ...... solated from British Columbia.

@nl

prefLabel

Characteristics of clinical Sh ...... solated from British Columbia.

@en

Characteristics of clinical Sh ...... solated from British Columbia.

@nl

P1476

Characteristics of clinical Sh ...... solated from British Columbia.

@en

P2093

Ana Cancarevic

http://www.w3.org/2001/XMLSchema#string

Ana Paccagnella

http://www.w3.org/2001/XMLSchema#string

Chad R Laing

http://www.w3.org/2001/XMLSchema#string

Hai Xu

http://www.w3.org/2001/XMLSchema#string

Kevin J Allen

http://www.w3.org/2001/XMLSchema#string

Lili R Mesak

http://www.w3.org/2001/XMLSchema#string

Linda Hoang

http://www.w3.org/2001/XMLSchema#string

Victor P J Gannon

http://www.w3.org/2001/XMLSchema#string

Yongxiang Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Diarrheagenic Escherichia coli

The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections

Contact-dependent inhibition of growth in Escherichia coli

Identification of Human-Pathogenic Strains of Shiga Toxin-Producing Escherichia coli from Food by a Combination of Serotyping and Molecular Typing of Shiga Toxin Genes

Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing

Genome evolution in major Escherichia coli O157:H7 lineages

Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection.

The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients.

Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002.

P304

878956

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/878956

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2013

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258338244

http://www.w3.org/2001/XMLSchema#string

P698

24199201

http://www.w3.org/2001/XMLSchema#string

P932

3807556

http://www.w3.org/2001/XMLSchema#string

Characteristics of clinical Shiga toxin-producing Escherichia coli isolated from British Columbia.

about

P2860

P2860

Characteristics of clinical Shiga toxin-producing Escherichia coli isolated from British Columbia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P932